» Authors » Mateusz Wierzbicki

Mateusz Wierzbicki

Explore the profile of Mateusz Wierzbicki including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 73
Citations 864
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Gharibkandi N, Wawrowicz K, Majkowska-Pilip A, Zelechowska-Matysiak K, Wierzbicki M, Bilewicz A
EJNMMI Radiopharm Chem . 2023 Oct; 8(1):26. PMID: 37821747
Background: In radionuclide therapy, to enhance therapeutic efficacy, an intriguing alternative is to ensure the simultaneous implementation of low- and high-LET radiation emitted from a one radionuclide. In the present...
12.
Kutwin M, Sosnowska M, Ostrowska A, Trzaskowski M, Lange A, Wierzbicki M, et al.
Int J Nanomedicine . 2023 Sep; 18:4839-4855. PMID: 37662685
Introduction: Graphene oxide (GO) is a single layer of carbon atoms with unique properties, which are beneficial due to its surface functionalisation by miRNA. miRNAs are a non-coding small form...
13.
Fraczek W, Kregielewski K, Wierzbicki M, Krzeminski P, Zawadzka K, Szczepaniak J, et al.
Materials (Basel) . 2023 Aug; 16(16). PMID: 37629892
Diamond nanoparticles, also known as nanodiamonds (NDs), exhibit remarkable, awe-inspiring properties that make them suitable for various applications in the field of skin care products. However, a comprehensive assessment of...
14.
Radzikowski D, Kalinska A, Kot M, Jaworski S, Wierzbicki M, Golebiewski M
Biomedicines . 2023 Aug; 11(8). PMID: 37626787
Mastitis prevention and treatment in dry cows are complex issues with limited solutions. The most common is intramammary antibiotic treatment. However, the effectiveness of this treatment varies among countries and...
15.
Wawrowicz K, Zelechowska-Matysiak K, Majkowska-Pilip A, Wierzbicki M, Bilewicz A
Nanoscale Adv . 2023 Jun; 5(12):3293-3303. PMID: 37325536
Convenient therapeutic protocols against hepatocellular carcinoma (HCC) exhibit low treatment effectiveness, especially in the context of long-term effects, which is primarily related to late diagnosis and high tumor heterogeneity. Current...
16.
Wierzbicki M, Zawadzka K, Wojcik B, Jaworski S, Strojny B, Ostrowska A, et al.
Int J Nanomedicine . 2023 Jun; 18:2821-2838. PMID: 37273285
Introduction: Diamond nanoparticles are considered to be one of the most cytocompatible carbon nanomaterials; however, their toxicity varies significantly depending on the analysed cell types. The aim was to investigate...
17.
Wojcik B, Zawadzka K, Jaworski S, Kutwin M, Sosnowska M, Ostrowska A, et al.
Nanotoxicology . 2023 Jun; 17(4):310-337. PMID: 37262345
Reports on the cytotoxicity of diamond nanoparticles (ND) are ambiguous and depend on the physicochemical properties of the material and the tested cell lines. Thus, the aim of this research...
18.
Kot M, Kalinska A, Jaworski S, Wierzbicki M, Smulski S, Golebiewski M
Int J Mol Sci . 2023 Apr; 24(7). PMID: 37047119
Digital dermatitis (DD) is the second most prevalent disease in dairy cattle. It causes significant losses for dairy breeders and negatively impacts cows' welfare and milk yield. Despite this, its...
19.
Zelechowska-Matysiak K, Wawrowicz K, Wierzbicki M, Budlewski T, Bilewicz A, Majkowska-Pilip A
Molecules . 2023 Mar; 28(6). PMID: 36985421
Recently, targeted nanoparticles (NPs) have attracted much attention in cancer treatment due to their high potential as carriers for drug delivery. In this article, we present a novel bioconjugate (DOX-AuNPs-Tmab)...
20.
Balaban J, Wierzbicki M, Zielinska-Gorska M, Sosnowska M, Daniluk K, Jaworski S, et al.
Nanotechnol Sci Appl . 2023 Jan; 16:1-18. PMID: 36699443
Aim: The experiments aimed to document the presence of the ACE2 receptor on human muscle cells and the effects of the interaction of these cells with the spike protein of...